DILIC
CELG

Dai-ichi Life Insurance Company’s Celgene Corp CELG Stock Holding History

Dai-ichi Life Insurance Company’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-57,500
Closed -$5.71M – 553
2019
Q3 		$5.71M Hold
57,500
– – 0.14% 173
2019
Q2 		$5.32M Buy
57,500
+148
+0.3% +$14.1K 0.13% 176
2019
Q1 		$5.41M Sell
57,352
-32,268
-36% -$2.82M 0.13% 170
2018
Q4 		$5.74M Sell
89,620
-1,092
-1% -$80.6K 0.16% 154
2018
Q3 		$8.12M Hold
90,712
– – 0.18% 125
2018
Q2 		$7.2M Sell
90,712
-12,486
-12% -$1.04M 0.17% 137
2018
Q1 		$9.21M Buy
103,198
+20,000
+24% +$1.92M 0.19% 115
2017
Q4 		$8.68M Sell
83,198
-33,990
-29% -$3.84M 0.17% 118
2017
Q3 		$17.1M Buy
117,188
+15,165
+15% +$2.07M 0.36% 52
2017
Q2 		$13.3M Buy
102,023
+22,940
+29% +$2.81M 0.29% 67
2017
Q1 		$9.84M Sell
79,083
-2,627
-3% -$314K 0.27% 90
2016
Q4 		$9.46M Buy
+81,710
New +$9.1M 0.28% 94

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Dai-ichi Life Insurance Company's CELG Position: Q4 2019 in Review

Dai-ichi Life Insurance Company sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 57,500 shares — an estimated $5.71M sold.

Dai-ichi Life Insurance Company first reported a position in CELG in Q4 2016 and held it in 12 quarters. The position peaked at $17.1M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Dai-ichi Life Insurance Company reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Dai-ichi Life Insurance Company sold 57,500 Celgene Corp shares in Q4 2019, an estimated $5.71M.
  • Dai-ichi Life Insurance Company first reported a position in Celgene Corp in Q4 2016 and held it in 12 quarters.
  • Dai-ichi Life Insurance Company's Celgene Corp position peaked at $17.1M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Dai-ichi Life Insurance Company's 13F filing for Q4 2019, filed 13 Feb 2020.